UBS O'Connor’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-96,060
| Closed | -$205K | – | 302 |
|
|
2025
Q1 | $205K | Sell |
96,060
-27,183
| -22% | -$57.9K | 0.01% | 221 |
|
|
2024
Q4 | $393K | Buy |
123,243
+52,320
| +74% | +$167K | 0.01% | 283 |
|
|
2024
Q3 | $947K | Sell |
70,923
-14,090
| -17% | -$188K | 0.02% | 281 |
|
|
2024
Q2 | $848K | Buy |
+85,013
| New | +$848K | 0.02% | 310 |
|